Difference between revisions of "HAEM5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 1: | Line 1: | ||
| + | Welcome! | ||
| + | |||
| + | * For assignments, please see the "Author" column below (3rd column from left). If no name is present, volunteer to create content! | ||
| + | * To volunteer, please '''[[Mailto:CCGA@cancergenomics.org|Contact us]]''' with your page of interest. | ||
| + | |||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
| − | |+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content | + | |+<big>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content</big> |
|- | |- | ||
!Disease (5th Edition)!!Page Type!!Author (5th Edition) (Note: please indicate trainees in parentheses)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review (5th Edition)!!Notes (5th Edition) | !Disease (5th Edition)!!Page Type!!Author (5th Edition) (Note: please indicate trainees in parentheses)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review (5th Edition)!!Notes (5th Edition) | ||
Revision as of 12:27, 20 December 2023
Welcome!
- For assignments, please see the "Author" column below (3rd column from left). If no name is present, volunteer to create content!
- To volunteer, please [us] with your page of interest.
| Disease (5th Edition) | Page Type | Author (5th Edition) (Note: please indicate trainees in parentheses) | Date Assigned to Author (5th Edition) | Target Completion Date (5th Edition) | Content Status (5th Edition)(Pending or Complete) | Date Completed by Author (5th Edition) | Associate Editor | Date of Last Editor Review (5th Edition) | Notes (5th Edition) | Correlated Prior Disease Name (4th Edition) | Correlated Prior Author (4th Edition) | Content Status (4th Edition)(Pending or Complete) | Date of Last Editor Review (4th Edition) | Notes (4th Edition) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHAPTER 2 (MYELOID PROLIFERATIONS AND NEOPLASMS) |
|
|
||||||||||||
| Clonal haematopoiesis | Disease | Fabiola Quintero-Rivera (FQR) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Clonal cytopenias of undetermined significance | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Chronic myeloid leukaemia | Disease | FQR | Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive | Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | Complete | Date page was created | ||||||||
| Chronic neutrophilic leukaemia | Disease | FQR | Chronic Neutrophilic Leukemia (CNL) | Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine **contributed equally | Complete | Date page was created | ||||||||
| Chronic eosinophilic leukaemia | Disease | FQR | Chronic Eosinophilic Leukemia, Not Otherwise Specified | Chelsea D. Kramish; Daynna J.Wolff | complete/pending faculty review | |||||||||
| Polycythaemia vera | Disease | FQR | Polycythemia Vera (PV) | Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | Complete | |||||||||
| Essential thrombocythaemia | Disease | FQR | Essential Thrombocythemia (ET) | Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN | Complete | |||||||||
| Primary myelofibrosis | Disease | FQR | Primary Myelofibrosis (PMF) | T. Niroshi Senaratne, UCLA | Complete | 8/4/2020 before submission |
||||||||
| Juvenile myelomonocytic leukaemia | Disease | FQR | Juvenile Myelomonocytic Leukemia (JMML) | Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology
Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories |
PENDING importing content and reference formatting | FQR has emailed SR several times, last 4/20/22 | ||||||||
| Myeloproliferative neoplasm, NOS | Disease | FQR | Myeloproliferative Neoplasm (MPN), Unclassifiable | Thomas Lee, MD, PhD, University of California, Los Angeles | Complete | |||||||||
| Cutaneous mastocytosis | Disease | FQR | Cutaneous Mastocytosis | S. Shawn Liu, MD, PhD and Thuy Phung, MD, PhD | Complete | |||||||||
| Systemic mastocytosis | Disease | FQR | Systemic Mastocytosis | Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | Complete | |||||||||
| Mast cell sarcoma | Disease | FQR | Mast Cell Sarcoma | Jordan Lowery, MD and Thuy Phung, MD, PhD Department of Pathology, University of South Alabama, Mobile, AL | Complete | |||||||||
| Myelodysplastic neoplasm with low blasts and 5q deletion | Disease | FQR | Myelodysplastic Syndrome (MDS) with Isolated del(5q) | Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG | Complete | |||||||||
| Myelodysplastic neoplasm with low blasts and SF3B1 mutation | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm with biallelic TP53 inactivation | Disease | Eric McGinnis (assigned to new 5th edition page - FQR is this reviewed?) | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | ||||||
| Myelodysplastic neoplasm with low blasts | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm, hypoplastic | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myelodysplastic neoplasm with increased blasts | Disease | FQR | Myelodysplastic Syndrome (MDS) with Excess Blasts | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Childhood myelodysplastic neoplasm with low blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Childhood myelodysplastic neoplasm with increased blasts | Disease | FQR | Refractory Cytopenia of Childhood | Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center | Complete | |||||||||
| Chronic myelomonocytic leukaemia | Disease | FQR | Chronic Myelomonocytic Leukemia (CMML) | Linsheng Zhang, MD, PhD | Complete | |||||||||
| Myelodysplastic/myeloproliferative neoplasm with neutrophilia | Disease | FQR | Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative | Linsheng Zhang, MD, PhD | Complete | |||||||||
| Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis | Disease | FQR | Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) | Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine | Complete | Date page was created | ||||||||
| Myelodysplastic/myeloproliferative neoplasm, NOS | Disease | FQR | Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable | Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia | Complete | |||||||||
| Acute promyelocytic leukaemia with PML::RARA fusion | Disease | Jennelle Hodge (JH)/ Malini Sathanoori (MS) | Acute Promyelocytic Leukemia (APL) with PML-RARA | Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 04/26/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with CBFB::MYH11 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Christine Bryke, MD Beth Israel Deaconess Medical Center, Boston, MA |
Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with DEK::NUP214 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | Jennelle C. Hodge, PhD, FACMG | Complete | 02/24/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with RBM15::MRTFA fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute myeloid leukaemia with BCR::ABL1 fusion | Disease | JH_MS | Acute Myeloid Leukemia (AML) with BCR-ABL1 | Kay Weng Choy MBBS, Monash Medical Centre | Complete | |||||||||
| Acute myeloid leukaemia with KMT2A rearrangement | Disease | JH_MS | Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Megan Piazza, Ph.D., Yiming Zhong, Ph.D., Shashi Shetty, Ph.D. | Complete | 03/01/2021-MS (re-review) | ||||||||
| Acute myeloid leukaemia with MECOM rearrangement | Disease | JH_MS | Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | Gordana Raca MD PhD, University of Southern California, Los Angeles | Complete | Need permission for figure? Update WHO? | ||||||||
| Acute myeloid leukaemia with NUP98 rearrangement | Disease | Eric McGinnis, MD | 12/20/23 | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||
| Acute myeloid leukaemia with NPM1 mutation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Mutated NPM1 | Xinjie Xu, PhD, FACMG | Complete | Add WHO reference | ||||||||
| Acute myeloid leukaemia with CEBPA mutation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA | Paul Defazio, MSc, Monash Health | Complete | |||||||||
| Acute myeloid leukaemia, myelodysplasia-related | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute myeloid leukaemia with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute myeloid leukaemia with minimal differentiation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Minimal Differentiation | Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | Complete | |||||||||
| Acute myeloid leukaemia without maturation | Disease | JH_MS | Acute Myeloid Leukemia (AML) without Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute myeloid leukaemia with maturation | Disease | JH_MS | Acute Myeloid Leukemia (AML) with Maturation | Jennelle C. Hodge, PhD, FACMG | Complete | |||||||||
| Acute basophilic leukaemia | Disease | JH_MS | Acute Basophilic Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||||
| Acute myelomonocytic leukaemia | Disease | JH_MS | Acute Myelomonocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute monocytic leukaemia | Disease | JH_MS | Acute Monoblastic and Monocytic Leukemia | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Acute erythroid leukaemia | Disease | JH_MS | Pure Erythroid Leukemia | Ashwini Yenamandra PhD FACMG | Complete | |||||||||
| Acute megakaryoblastic leukaemia | Disease | JH_MS | Acute Megakaryoblastic Leukemia (AMKL) | Fei Yang, MD, FACMG Oregon Health & Science University |
Complete | |||||||||
| Myeloid sarcoma | Disease | JH_MS | Myeloid Sarcoma | Yalda Naeini, MD, School of Medicine at University of California Los Angeles Fabiola Quintero-Rivera, MD, FACMG, School of Medicine at University of California Irvine | Complete | |||||||||
| RESOLVE 4th edition AML-Related NON-WHO entities content | Acute Myeloid Leukemia (AML) with Mutated FLT3 + Acute Myeloid Leukemia (AML) with NUP214-ABL1 + Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 | ISSUE - FIX | ||||||||||||
| Myeloid neoplasm post cytotoxic therapy | Disease | JH_MS | Therapy-Related Myeloid Neoplasms | Shawn A. Silver, DO, Shashi Shetty, Ph.D. | Complete | Check reference format | ||||||||
| Myeloid neoplasms associated with germline predisposition | Disease | ISSUE - FIX ("This is a massive merge of all pages on the Myeloid Neoplasms with Germline Predisposition overiew page, plus new content" | JH_MS | |||||||||||
| Myeloid proliferations associated with Down syndrome | Disease | JH_MS | MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome | Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | Complete (all three pages) | |||||||||
| Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement | Jay Alden, DO | Complete | |||||||||
| Myeloid/lymphoid neoplasm with PDGFRB rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement | Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD | Complete | |||||||||
| Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | FQR | Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement | Yanna Ding, MD PhD | Complete | |||||||||
| Myeloid/lymphoid neoplasm with JAK2 rearrangement | Disease | ISSUE- FIX
|
FQR | Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + consider a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 (Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)) + another non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 (Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io) ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff | Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff | Complete | ||||||||
| Myeloid/lymphoid neoplasm with FLT3 rearrangement | Disease | ISSUE - FIX | FQR | Acute Myeloid Leukemia (AML) with Mutated FLT3 (HAEM4:Acute Myeloid Leukemia (AML) with Mutated FLT3 ) ???No prior content on this page??? I don't think this is a WHO entity from the 4th edition. | ||||||||||
| Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes | Disease | FQR | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia with BCR::ABL1 fusion | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | Tracy Tucker, PhD, FCCMG | Complete | |||||||||
| Mixed-phenotype acute leukaemia with KMT2A rearrangement | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | Tracy Tucker, PhD, FCCMG | Complete | |||||||||
| Acute leukaemia of ambiguous lineage with other defined genetic alterations | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Mixed-phenotype acute leukaemia, B/myeloid | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | Complete | |||||||||
| Mixed-phenotype acute leukaemia, T/myeloid | Disease | JH_MS | Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | Complete | |||||||||
| Mixed-phenotype acute leukaemia, rare types | Disease | JH_MS | Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | PENDING | |||||||||
| Acute leukaemia of ambiguous lineage, NOS | Disease | JH_MS | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | NEW (No Prior) | |||||||
| Acute undifferentiated leukaemia | Disease | JH_MS | Acute Undifferentiated Leukemia | Amelia Nakanishi, MD and Shashi Shetty, PhD | Complete | Check reference format | ||||||||
| CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) |
|
|
||||||||||||
| Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm | Disease | Greg Corboy (GC) | ||||||||||||
| Blastic plasmacytoid dendritic cell neoplasm | Disease | GC | Hao Liu, MD and Daynna J. Wolff, PhD | |||||||||||
| Langerhans cell histiocytosis | Disease | GC | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | |||||||||||
| Langerhans cell sarcoma | Disease | GC | Dr Malaika Perchard BSci(MedSci), MBBS, FRACP, FRCPA, (Paediatric Haematologist) Pathology Queensland | |||||||||||
| Indeterminate dendritic cell tumour | Disease | GC | ||||||||||||
| Interdigitating dendritic cell sarcoma | Disease | GC | ||||||||||||
| Juvenile xanthogranuloma | Disease | GC | ||||||||||||
| Erdheim-Chester disease | Disease | GC | ||||||||||||
| Rosai-Dorfman Disease | Disease | GC | ||||||||||||
| ALK-positive histiocytosis | Disease | GC | ||||||||||||
| Histiocytic sarcoma | Disease | GC | Marie-France Gagnon, MD, Mayo Clinic, Xinjie Xu, PhD FACMG, Mayo Clinic | |||||||||||
| CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
|
|||||||||||
| Reactive B-cell rich lymphoid proliferations that can mimic lymphoma | Disease | GC | ||||||||||||
| IgG4-related disease | Disease | GC | ||||||||||||
| Unicentric Castleman disease | Disease | GC | ||||||||||||
| Idiopathic multicentric Castleman disease | Disease | GC | ||||||||||||
| KSHV/HHV8-associated multicentric Castleman disease | Disease | GC | Sudha Arumugam, MD | |||||||||||
| B-lymphoblastic leukaemia/lymphoma | Disease | Holli Drendel (HD) | ||||||||||||
| B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy | Disease | HD | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | |||||||||||
| B-lymphoblastic leukaemia/lymphoma with hypodiploidy | Disease | HD | Ashwini Yenamandra PhD FACMG Lisa Smith PhD FACMG Yassmine Akkari PhD FACMG | |||||||||||
| B-lymphoblastic leukaemia/lymphoma with iAMP21 | Disease | HD | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | |||||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion | Disease | HD | Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG | |||||||||||
| B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features | Disease | HD | Mark G. Evans, MD, University of California, Irvine Fabiola Quintero-Rivera, MD, University of California, Irvine | |||||||||||
| B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement | Disease | HD | Yassmine Akkari Nicolas Millan | |||||||||||
| B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion | Disease | HD | Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG Cancer Category/Type B-Lymphoblastic Leukemia/Lymphoma | |||||||||||
| B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features | Disease | HD | ||||||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion | Disease | HD | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | |||||||||||
| B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion | Disease | HD | Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | |||||||||||
| B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion | Disease | HD | ||||||||||||
| B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations | Disease | HD | ||||||||||||
| B-lymphoblastic leukaemia/lymphoma, NOS | Disease | HD | ||||||||||||
| RESOLVE 4th edition ALL-Related NON-WHO entities content | B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 + B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 + B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements + B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions + B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) + B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ISSUE - FIX | ISSUE - FIX | |||||||||||
| Monoclonal B-cell lymphocytosis | Disease | Shivani Golem (SG) | ||||||||||||
| Chronic lymphocytic leukaemia/small lymphocytic lymphoma | Disease | SG | Jamie Nagy, PhD, University of Iowa Honey Reddi, PhD | |||||||||||
| Hairy cell leukaemia | Disease | SG | *Snehal Patel, MD, PhD | |||||||||||
| Splenic marginal zone lymphoma | Disease | SG | *Snehal Patel, MD, PhD | |||||||||||
| Splenic diffuse red pulp small B-cell lymphoma | Disease | SG | *Snehal Patel, MD, PhD | |||||||||||
| Splenic B-cell lymphoma/leukaemia with prominent nucleoli | Disease | SG | *Snehal Patel, MD, PhD | |||||||||||
| Lymphoplasmacytic lymphoma | Disease | SG | Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | |||||||||||
| Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue | Disease | SG | ||||||||||||
| Primary cutaneous marginal zone lymphoma | Disease | SG | ||||||||||||
| Nodal marginal zone lymphoma | Disease | SG | Andrew Ly, DO and Shivani Golem, PhD, FACMG | |||||||||||
| Paediatric nodal marginal zone lymphoma | Disease | SG | * Kathleen M. Schieffer, PhD * Ruthann Pfau, PhD | |||||||||||
| In situ follicular B-cell neoplasm | Disease | SG | Rachel D. Burnside, PhD, MBA, FACMGG | |||||||||||
| Follicular lymphoma | Disease | SG | Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | |||||||||||
| Paediatric-type follicular lymphoma | Disease | SG | *Kathleen M. Schieffer, PhD *Ruthann Pfau, PhD, FACMG | |||||||||||
| Duodenal-type follicular lymphoma | Disease | SG | ||||||||||||
| Primary cutaneous follicle centre lymphoma | Disease | SG | Linlin Gao, MD, PhD and Shivani Golem, PhD, FACMG | |||||||||||
| In situ mantle cell neoplasm | Disease | SG | Rina Kansal, MD; Versiti Blood Center of Wisconsin | |||||||||||
| Mantle cell lymphoma | Disease | SG | * Mahsa Khanlari, MD * Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | |||||||||||
| Leukaemic non-nodal mantle cell lymphoma | Disease | SG | ||||||||||||
| Transformations of indolent B-cell lymphomas | Disease | SG | ||||||||||||
| Diffuse large B-cell lymphoma, NOS | Disease | GC | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | |||||||||||
| T-cell/histiocyte-rich large B-cell lymphoma | Disease | GC | ||||||||||||
| Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements | Disease | GC | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |||||||||||
| ALK-positive large B-cell lymphoma | Disease | GC | Manando Nakasaki, MD, PhD (University of California, Irvine) Fabiola Quintero-Rivera, MD, FACMG (University of California, Irvine) | |||||||||||
| Large B-cell lymphoma with IRF4 rearrangement | Disease | GC | *Afia Hasnain, MBBS, PhD | |||||||||||
| High grade B-cell lymphoma with 11q aberrations | Disease | GC | Lauren Shealy, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | |||||||||||
| Lymphomatoid granulomatosis | Disease | GC | ||||||||||||
| EBV-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
| Diffuse large B-cell lymphoma associated with chronic inflammation | Disease | GC | ||||||||||||
| Fibrin-associated large B-cell lymphoma | Disease | GC | ||||||||||||
| Fluid overload-associated large B-cell lymphoma | Disease | GC | ||||||||||||
| Plasmablastic lymphoma | Disease | GC | Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | |||||||||||
| Primary large B-cell lymphoma of immune-privileged sites | Disease | GC | Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | |||||||||||
| Primary cutaneous diffuse large B-cell lymphoma, leg type | Disease | GC | ||||||||||||
| Intravascular large B-cell lymphoma | Disease | GC | Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |||||||||||
| Primary mediastinal large B-cell lymphoma | Disease | GC | ||||||||||||
| Mediastinal grey zone lymphoma | Disease | GC | ||||||||||||
| High-grade B-cell lymphoma, NOS | Disease | GC | Aiko Otsubo, PhD, Indiana University | |||||||||||
| Burkitt lymphoma | Disease | GC | Becky Leung, MBBS (Hons), BSc, Pathology Queensland | |||||||||||
| Primary effusion lymphoma | Disease | GC | ||||||||||||
| KSHV/HHV8-positive diffuse large B-cell lymphoma | Disease | GC | ||||||||||||
| KSHV/HHV8-positive germinotropic lymphoproliferative disorder | Disease | GC | ||||||||||||
| Hyperplasias arising in immune deficiency/dysregulation | Disease | GC | ||||||||||||
| Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation | Disease | GC | Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | |||||||||||
| EBV-positive mucocutaneous ulcer | Disease | GC | ||||||||||||
| Lymphomas arising in immune deficiency / dysregulation | Disease | GC | ||||||||||||
| Inborn error of immunity-associated lymphoid proliferations and lymphomas | Disease | GC | ||||||||||||
| Classic Hodgkin lymphoma | Disease | GC | Patricia V. Hernandez, M.D., Washington University School of Medicine | |||||||||||
| Nodular lymphocyte predominant Hodgkin lymphoma | Disease | GC | ||||||||||||
| Cold agglutinin disease | Disease | SG | ||||||||||||
| IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
| Non-IgM monoclonal gammopathy of undetermined significance | Disease | SG | ||||||||||||
| Monoclonal gammopathy of renal significance | Disease | SG | ||||||||||||
| Immunoglobulin-related (AL) amyloidosis | Disease | SG | Heather E. Williams, PhD, MS, PgD, ErCLG | |||||||||||
| Monoclonal immunoglobulin deposition disease | Disease | SG | Chen Yang, MD, PhD, University of Michigan | |||||||||||
| Mu heavy chain disease | Disease | SG | ||||||||||||
| Gamma heavy chain disease | Disease | SG | Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA | |||||||||||
| Alpha heavy chain disease | Disease | SG | ||||||||||||
| Plasmacytoma | Disease | SG | ||||||||||||
| Plasma cell myeloma / multiple myeloma | Disease | SG | *Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | |||||||||||
| Plasma cell neoplasms with associated paraneoplastic syndrome | Disease | SG | Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD | |||||||||||
| CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) |
|
|
||||||||||||
| Kikuchi-Fujimoto disease | Disease | Sumi Kitahara (SK) | ||||||||||||
| Autoimmune lymphoproliferative syndrome | Disease | SK | ||||||||||||
| Indolent T-lymphoblastic proliferation | Disease | SK | ||||||||||||
| T-lymphoblastic leukaemia / lymphoma, NOS | Disease | HD | ||||||||||||
| Early T-precursor lymphoblastic leukaemia / lymphoma | Disease | HD | Fei Yang, MD, FACMG, Kaiser Permanente Northwest | |||||||||||
| T-prolymphocytic leukaemia | Disease | SK | ||||||||||||
| T-large granular lymphocytic leukaemia | Disease | SK | *Michelle Don, MD, MS | |||||||||||
| NK-large granular lymphocytic leukaemia | Disease | SK | Michelle Don, MD | |||||||||||
| Adult T-cell leukaemia/lymphoma | Disease | SK | Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | |||||||||||
| Sezary syndrome | Disease | SK | Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | |||||||||||
| Aggressive NK-cell leukaemia | Disease | SK | Shanelle De Lancy, MD, Shashirekha Shetty, PhD | |||||||||||
| Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
| Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder | Disease | SK | ||||||||||||
| Mycosis fungoides | Disease | SK | Jane Scribner, MD and Daynna J. Wolff, PhD | |||||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis | Disease | SK | ||||||||||||
| Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma | Disease | SK | Theresa Spivey, MD, Shashirekha Shetty, PhD | |||||||||||
| Subcutaneous panniculitis-like T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous gamma/delta T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma | Disease | SK | ||||||||||||
| Primary cutaneous peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
| Indolent T-cell lymphoma of the gastrointestinal tract | Disease | SK | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | |||||||||||
| Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract | Disease | SK | ||||||||||||
| Enteropathy-associated T-cell lymphoma | Disease | SK | *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD | |||||||||||
| Monomorphic epitheliotropic intestinal T-cell lymphoma | Disease | SK | Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD | |||||||||||
| Intestinal T-cell lymphoma, NOS | Disease | SK | Derick Okwan MD, PhD (Stanford Medicine, CA) Sumire Kitahara MD (Cedars-Sinai, CA) | |||||||||||
| Hepatosplenic T-cell lymphoma | Disease | SK | *Michelle Don, MD, MS | |||||||||||
| ALK-positive anaplastic large cell lymphoma | Disease | SK | ||||||||||||
| ALK-negative anaplastic large cell lymphoma | Disease | SK | Miguel Gonzalez Mancera, MD Sumire Kitahara, MD Cedars-Sinai, Los Angeles, CA | |||||||||||
| Breast implant-associated anaplastic large cell lymphoma | Disease | SK | Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | |||||||||||
| Nodal TFH cell lymphoma, angioimmunoblastic-type | Disease | SK | * Sara Akhavanfard, M.D., Ph.D. * Ruthann Pfau, Ph.D., FACMG | |||||||||||
| Nodal TFH cell lymphoma, follicular-type | Disease | SK | ||||||||||||
| Nodal TFH cell lymphoma, NOS | Disease | SK | Hans Magne Hamnvåg, MD Kamran Mirza, MD, PhD | |||||||||||
| Peripheral T-cell lymphoma, NOS | Disease | SK | ||||||||||||
| EBV-positive nodal T- and NK-cell lymphoma | Disease | SK | ||||||||||||
| Extranodal NK/T-cell lymphoma | Disease | SK | ||||||||||||
| Severe mosquito bite allergy | Disease | SK | ||||||||||||
| Hydroa vacciniforme lymphoproliferative disorder | Disease | SK | ||||||||||||
| Systemic chronic active EBV disease | Disease | SK | ||||||||||||
| Systemic EBV-positive T-cell lymphoma of childhood | Disease | SK | *Lisa A. Lansdon, PhD & Linda D. Cooley, MD, MBA | |||||||||||
| CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) |
|
|
||||||||||||
| Follicular dendritic cell sarcoma | Disease | GC | Anna Heimes Dillon, MD and Shivani Golem, PhD, FACMG | |||||||||||
| EBV-positive inflammatory follicular dendritic cell sarcoma | Disease | GC | ||||||||||||
| Fibroblastic reticular cell tumour | Disease | GC | ||||||||||||
| Intranodal palisaded myofibroblastoma | Disease | GC | ||||||||||||
| Littoral cell angioma | Disease | GC | ||||||||||||
| Splenic hamartoma | Disease | GC | ||||||||||||
| Sclerosing angiomatoid nodular transformation (SANT) of spleen | Disease | GC | ||||||||||||
| CHAPTER 7 (GENETIC TUMOUR SYNDROMES) |
|
|
||||||||||||
| Fanconi anaemia | Disease | NA | ||||||||||||
| Bloom syndrome | Disease | NA | ||||||||||||
| Ataxia-telangiectasia syndrome | Disease | NA | ||||||||||||
| RASopathies | Disease | NA |